Mandimycin, which targets a different essential fungi cell resource than other antifungal drugs, should harm other cell types as collateral — but doesn’t.

Once considered obscure or opportunistic, invasive fungal infections are now surfacing with alarming frequency - and in ...

The World Health Organization (WHO) this week published two reports spotlighting gaps in adequate medicines and diagnostic ...

More innovative research and development (R&D) is needed to address lack of medicines and diagnostic tools for invasive fungal diseases, the World Health Organization has said.In a statement, Dr ...

WHO’s report on antifungal drugs highlights that, in the past decade, only four new antifungal drugs have been approved by ...

Some fungal diseases in humans no longer respond to medicines, which increases the risk of severe illness and death as well ...

Fungal diseases are growing increasingly resistant to treatment, posing a threat to global health, the World Health ...

Cases of Candida auris, a dangerous, drug-resistant fungus, are rising in hospitals and senior care centers across the U.S.

In brief Candida auris infections have surged from 52 cases in 2016 to over 4,500 in 2023, CDC data shows The fungus kills ...

A fungal superbug is spreading through hospitals and nursing homes at an 'alarming rate,' with the CDC recently calling it an ...